You are here

Novo Nordisk

Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep

Fierce Pharma

Thu, 05/4/17 - 10:08 am

Novo Nordisk launches Xultophy diabetes therapy in U.S.

Mass Device

Thu, 05/4/17 - 09:45 am

type 2 diabetes

insulin degludec

Novo Nordisk reaches whistleblower settlement in 'white-coat' sales scheme lawsuit

Fierce Pharma

Mon, 05/1/17 - 11:43 am

whistleblower lawsuits

5 Big Drugmakers With Important Catalysts in May

Motley Fool

Sun, 04/30/17 - 01:00 pm

nonacog beta pegol

Meet the lawyer trying to pry drug pricing secrets out of Big Pharma

Stat

Thu, 04/20/17 - 09:02 pm

Seeking a lift, Novo launches ultrafast-acting insulin in European markets

Fierce Pharma

Fri, 04/14/17 - 10:13 am

3 Tremendously Promising Diabetes Drugs Potentially on the Way

Motley Fool

Sun, 03/26/17 - 12:02 pm

Lexicon Pharmaceuticals

Novo Basal Insulin Gets CHMP Nod to Update Label

Investopedia

Sat, 03/25/17 - 12:15 pm

Novo Nordisk in Talks to Buy Global Blood Therapeutics

Investopedia

Fri, 03/10/17 - 11:49 am

Global Blood Therapeutics

Novo Nordisk Named on the FORTUNE 100 Best Companies to Work For® List for Ninth Consecutive Year

Yahoo

Thu, 03/9/17 - 11:18 am

Fortune magazine

Novo rejigs U.S. team as passed-over CEO candidate heads for the door

Fierce Pharma

Wed, 03/1/17 - 11:38 am

Top 10 U.S. patent losses of 2017

Fierce Pharma

Thu, 02/23/17 - 09:29 am

Sandostatin LAR

Bristol-Myers Squibb

Gilead Sciences

Novo Nordisk Misses Q4 Earnings Estimates

Investopedia

Sat, 02/4/17 - 09:58 am

Teva Confirms Generic Victoza® Patent Challenge in the United States

Yahoo

Thu, 02/2/17 - 09:20 am

Teva Pharmaceutical

Novo Nordisk Slumps on Disappointing Profit, Guidance Cut

TheStreet.com

Thu, 02/2/17 - 09:15 am

Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit

Yahoo/Reuters

Tue, 01/31/17 - 10:09 am

price collusion

Novo Nordisk slumps 5.4% on U.S. price fixing lawsuit

Marketwatch

Thu, 01/12/17 - 09:16 am

price collusion

Sanofi sues Novo over 'misleading' Tresiba marketing materials

Fierce Pharma

Wed, 12/28/16 - 11:21 am

ADA guidelines highlight new Jardiance label

BioPharma Dive

Mon, 12/19/16 - 11:39 am

Boehringer Ingelheim

Novo Nordisk: Why The Diabetes Giant Will Continue To Grow

Seeking Alpha

Tue, 12/13/16 - 10:14 am

Pages